Biopharma ramps up lobbying spend as drug pricing legislation nears
The top biopharma companies in the world collectively spent more than $40 million in just the first quarter of 2021 on lobbying Congress as part …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
